MRS2 and acute myeloid leukemia: Recently, many potential protein biomarkers have been reported in the literature for the diagnosis of AML, e.g., complement factor C7, complement factor H, HPT (Haptoglobin), ApoE (Apolipoprotein E), plasminogen and ApoA1 (Apolipoprotein A1), via proteomics techniques [13,32,33,34].